BBP
TEVA icon

Banco BTG Pactual’s Teva Pharmaceuticals TEVA Stock Holding History

Banco BTG Pactual’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,344
Closed -$260K – 292
2025
Q4 		$260K Buy
+8,344
New +$206K 0.04% 126
2025
Q3 		– Sell
-37,131
Closed -$622K – 215
2025
Q2 		$622K Hold
37,131
– – 0.13% 95
2025
Q1 		$571K Buy
37,131
+16,598
+81% +$296K 0.14% 100
2024
Q4 		$437K Sell
20,533
-1,907
-8% -$34.7K 0.1% 109
2024
Q3 		$404K Buy
+22,440
New +$393K 0.1% 92

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Banco BTG Pactual's TEVA Position: Q1 2026 in Review

Banco BTG Pactual sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 8,344 shares — an estimated $260K sold.

Banco BTG Pactual first reported a position in TEVA in Q3 2024 and held it in 5 quarters. The position peaked at $622K in Q2 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Banco BTG Pactual reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Banco BTG Pactual sold 8,344 Teva Pharmaceuticals shares in Q1 2026, an estimated $260K.
  • Banco BTG Pactual first reported a position in Teva Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Banco BTG Pactual's Teva Pharmaceuticals position peaked at $622K in Q2 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Banco BTG Pactual's 13F filing for Q1 2026, filed 13 May 2026.